64CuCl2treatment: preliminary data on recurrent glioblastoma patients

被引：0
|
作者：
Stanimirovic, D. [1 ]
Milakovic, D. [1 ]
Mijatovic, J. [1 ]
Rakita, I. [1 ]
Vuleta, G. [1 ]
Basile, M. [2 ]
Valentini, S. [2 ]
机构：
[1] Univ Clin Ctr Republ Srpska, Banja Luka, Bosnia & Herceg
[2] ACOM Adv Ctr Oncol Macerata SRL, Montecosaro, MC, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0614
引用
收藏
页码：S673 / S674
页数：2
相关论文
共 50 条
  • [21] Two different treatment options for patients with recurrent glioblastoma in the same hospital
    Ramirez, P.
    Villanego, I.
    Iglesias, I.
    Rodriguez, F.
    Lopez, J. A.
    Morillas, M.
    Lao, V.
    Gil-Salu, J. L.
    ANNALS OF ONCOLOGY, 2015, 26 : 35 - 35
  • [22] DISCRIMINATION OF CLINICALLY IMPACTFUL TREATMENT RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS RECEIVING BEVACIZUMAB TREATMENT
    Singleton, Kyle W.
    Johnston, Sandra K.
    Hawkins-Daarud, Andrea
    Rickertsen, Cassandra R.
    De Leon, Gustavo
    Kunkel, Lauren
    Whitmire, Scott A.
    Clark-Swanson, Kamala
    Bendok, Bernard
    Mrugala, Maciej
    Porter, Alyx
    Swanson, Kristin R.
    NEURO-ONCOLOGY, 2017, 19 : 163 - 163
  • [23] PHASE 0/2 STUDY OF RIBOCICLIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA
    Tien, An-Chi
    Bao, Xun
    Derogatis, Alanna
    Kim, Seongho
    Mehta, Shwetal
    Li, Jing
    Sanai, Nader
    NEURO-ONCOLOGY, 2018, 20 : 21 - 21
  • [24] AUTOPSY STUDY ON THE EFFECTS OF TUMOR TREATMENT FIELDS IN RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS AND TRIAL DESIGN
    Hurrell, Sarah
    Cochran, Elizabeth
    McGarry, Sean
    Connelly, Jennifer M.
    Schmainda, Kathleen M.
    Rand, Scott
    Mueller, Wade M.
    LaViolette, Peter
    NEURO-ONCOLOGY, 2017, 19 : 10 - 10
  • [25] Early assessment of recurrent glioblastoma response to bevacizumab treatment by diffusional kurtosis imaging: a preliminary report
    Lee, Chu-Yu
    Kalra, Amandeep
    Spampinato, Maria, V
    Tabesh, Ali
    Jensen, Jens H.
    Helpern, Joseph A.
    Falangola, Maria de Fatima
    Van Horn, Mark H.
    Giglio, Pierre
    NEURORADIOLOGY JOURNAL, 2019, 32 (05): : 317 - 327
  • [26] TREATMENT OUTCOMES OF STEREOTACTIC RADIOTHERAPY COMBINED WITH BEVACIZUMAB THERAPY IN RECURRENT GLIOBLASTOMA PATIENTS
    Sonoda, Yukihiko
    Matsuda, Ken-ichiro
    NEURO-ONCOLOGY, 2018, 20 : 24 - 24
  • [27] CYBERKNIFE HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY FOR THE PATIENTS OF RECURRENT GLIOBLASTOMA WITH BEVACIZUMAB TREATMENT FAILURE
    Tabei, Yusuke
    Sato, Kengo
    Ichi, Shunsuke
    NEURO-ONCOLOGY, 2019, 21 : 211 - 211
  • [28] Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma
    Hamza, Mohamed A.
    Mandel, Jacob J.
    Conrad, Charles A.
    Gilbert, Mark R.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    DeGroot, John F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 119 (01) : 135 - 140
  • [29] Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma
    Mohamed A. Hamza
    Jacob J. Mandel
    Charles A. Conrad
    Mark R. Gilbert
    W. K. Alfred Yung
    Vinay K. Puduvalli
    John F. DeGroot
    Journal of Neuro-Oncology, 2014, 119 : 135 - 140
  • [30] ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma
    Asenjo Garcia, Beatriz
    Navarro Guirado, Felix
    Raya, Fatima Nagib
    Vidal Denis, Maria
    Bravo Rodriguez, Francisco
    Galan Montenegro, Pedro
    ACTA RADIOLOGICA, 2020, 61 (03) : 404 - 413
12345